Additionally, Volkan S. et al. showed that the antioxidants supplementation may accelerate early tumors or precancerous lesions growth in elevated-risk populations (like smokers and chronic obstructive pulmonary disease patients who receive NAC to reduce mucus production) because the somatic p53 mutations occur late in the tumor progression process [277]. This evidence concerns the gene TP53 and neoplasm.